Hospital Management

Daily Newsletter

09 August 2023

Daily Newsletter

AIG Hospitals implements OptraSCAN’s digital pathology platform

OS Ultra will aid the facility to optimise its diagnostic approach and streamline workflows.

Asian Institute of Gastroenterology unit AIG Hospitals in India has deployed the OS-Ultra high-speed digital pathology solution from OptraSCAN.

The latest development is part of AIG Hospitals’ strategy to bolster its pathology practices, ANI reported.

AIG Hospitals selected OS Ultra for optimising its diagnostic approach, facilitating advanced AI-powered analytics, streamlining workflows and boosting innovation in its pathology practices.

The hospital introduced the OS-Ultra scanner during the inauguration of its pathology department.

AIG Hospitals pathology director and chief Dr Anuradha Sekaran said: “Our primary objective is to deliver the highest quality diagnosis to our patients, and the adoption of OptraSCAN’s digital pathology solution is a significant step in that direction.

“It enables us to optimise workload distribution, facilitate instant specialist opinions, enable remote case reviews, and simplify tumour board joint reviews.

“OptraSCAN’s whole slide scanners are both affordable and efficient, providing excellent image quality.”

The 800-bed super specialty hospital provides advanced medical services and TelePathology services for remote assessment.

The facility also features a lab medicine department to carry out precise reporting round the clock.

OptraSCAN founder and CEO Abhi Gholap said: “We look forward to collaborating closely with AIG Hospitals and supporting them in their mission to deliver exceptional patient care.”

OptraSCAN provides digital pathology solutions, aiding healthcare groups to move from conventional glass slides to digitised images for improving diagnostics.

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.